← Leaderboards
Patricia A Thistlethwaite
University Of California San Diego
$7,394,079
Attributed
$8,265,066
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $977.3K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,265,066 · 4
By mechanism
R01$8,265,066 · 4
Top collaborators
- Mark Mercola4 shared
Most similar at University Of California San Diego
Same institution · by research overlap
- Pamela L Mellon$36,611,301
Others in their field
Top investigators on “Cell Proliferation”
- John M Lachin · George Washington University$118,921,924
- David M Nathan · Massachusetts Institute Of Technology$118,921,924
- David Heimbrook · Leidos Biomedical Research, Inc.$103,164,048
- Timothy J Eberlein · Washington University$49,931,668
- Deirdre R. Meldrum · University Of Washington$37,202,510
- Robert A Weinberg · Whitehead Institute For Biomedical Res$32,735,166
Research focus
Cell ProliferationPulmonary HypertensionPharmaceutical PreparationsSignal TransductionPulmonary Arterial HypertensionHypoxiaCellsPulmonary Artery StructurePathologicBaseSmooth Muscle MyocytesPreventPhenotypeMorbidity - Disease RatePathway InteractionsBlood VesselsRodentSeveritiesLaboratoriesLigand BindingLungEndothelial CellsMolecularVascular Smooth Muscle
Grant awards (19)
NOTCH3 ECD as a Serum Biomarker for Pulmonary Arterial Hypertension$613,624
R01 · FY2025 · HL · contact PI
NOTCH3 ECD as a Serum Biomarker for Pulmonary Arterial Hypertension$627,186
R01 · FY2024 · HL · contact PI
Small Molecule NOTCH Inhibitors for the treatment of pulmonary hypertension$410,882
R01 · FY2019 · HL
NOTCH3 Signaling in Pulmonary Hypertension$529,102
R01 · FY2018 · HL · contact PI
Small Molecule NOTCH Inhibitors for the treatment of pulmonary hypertension$416,493
R01 · FY2018 · HL
NOTCH3 Signaling in Pulmonary Hypertension$528,970
R01 · FY2017 · HL · contact PI
Small Molecule NOTCH Inhibitors for the treatment of pulmonary hypertension$448,345
R01 · FY2017 · HL
Small Molecule NOTCH Inhibitors for the treatment of pulmonary hypertension$466,255
R01 · FY2016 · HL
NOTCH3 Signaling in Pulmonary Hypertension$543,378
R01 · FY2015 · HL · contact PI
NOTCH3 Signaling in Pulmonary Hypertension$551,527
R01 · FY2014 · HL · contact PI
Molecular Mechanisms of Pulmonary Hypertension$386,250
R01 · FY2011 · HL · contact PI
Molecular Mechanisms of Pulmonary Hypertension$386,250
R01 · FY2010 · HL · contact PI
Molecular Mechanisms of Pulmonary Hypertension$386,250
R01 · FY2009 · HL · contact PI
Molecular Mechanisms of Pulmonary Hypertension$386,250
R01 · FY2008 · HL · contact PI
Molecular Mechanisms of Pulmonary Hypertension$382,708
R01 · FY2007 · HL · contact PI
Molecular Mechanisms of Pulmonary Hypertension$304,000
R01 · FY2005 · HL
Molecular Mechanisms of Pulmonary Hypertension$301,296
R01 · FY2004 · HL
Molecular Mechanisms of Pulmonary Hypertension$300,100
R01 · FY2003 · HL
Molecular Mechanisms of Pulmonary Hypertension$296,200
R01 · FY2002 · HL